The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration
Open accessAbstract
Stress and stress hormones, glucocorticoids (GCs), exert widespread actions in central nervous system, ranging from the regulation of gene transcription, cellular signaling, modulation of synaptic structure, and transmission and glial function to behavior. Their actions are mediated by glucocorticoid and mineralocorticoid receptors which are nuclear receptors/transcription factors. While GCs primarily act to maintain homeostasis by inducing physiological and behavioral adaptation, prolonged exposure to stress and elevated GC levels may result in neuro- and psychopathology. There is now ample evidence for cause-effect relationships between prolonged stress, elevated GC levels, and cognitive and mood disorders while the evidence for a link between chronic stress/GC and neurodegenerative disorders such as Alzheimer’s (AD) and Parkinson’s (PD) diseases is growing. This brief review considers some of the cellular mechanisms through which stress and GC may contribute to the pathogenesis of AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study found that in mice models of AD, heightened stress and glucocorticoid production aided in the production of beta-amyloid, a key feature of AD, and worsening cognitive and memory deficits [79].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [79]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice research, the administration of glucocorticoid receptor antagonists resulted in improved cognition and reduced AD pathologies, supporting findings that glucocorticoid signaling influences and likely plays a contributing role in the development and progression of AD pathologies.”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [79]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through an interplay of inflammation due to immune response and subsequent cytokine release and a lack of downregulation normally executed by GCs, neuroinflammation persists, leading to the atrophy of neurons in critical brain areas, such as the hippocampus [79,98].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“supporting findings that glucocorticoid signaling influences and likely plays a contributing role in the development and progression of AD pathologies.”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“[121] as a principle pathological marker to monitor the progression and severity of PD.”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Epigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177 · cited 1×
“The first evidence of epigenetic programing in the brain by early life adversity showed that poor maternal care in rats leads to methylation of exon 1 7 in the GR promoter, being accompanied by aberrant behaviors and altered HPA axis responses during adulthood [32, 33].”
BackgroundPhysiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 5×
“of well-being or disruption of organism homeostasis [1].”
BackgroundInfluentialStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531 · cited 1×
“Subsequently, similar mechanisms were reported in humans who had experienced childhood adversity [34] and in infants born to depressed mothers [35].”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
REUL, J. M. H. M., & KLOET, E. R. D. (1985) · Endocrinology · doi:10.1210/endo-117-6-2505 · Cited by 2,580 · cited 1×
“5 nM) for GC compared to GR (K d = 5 nM), which means that, at basal GC levels, MR is occupied and activated [16] whereas GR is only activated when GC levels reach a certain level, for example, during the circadian peak of GC secretion and during stress [17].”
BackgroundBallard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · cited 2×
“Furthermore, postmortem studies as well as analyses of serum and cerebrospinal fluid from PD showed high levels of proinflammatory mediators such as TNF-𝛼, IL-1𝛽, iNOS, IFN-𝛾, and COX-2 [149].”
BackgroundReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 1×
“TREM2 is specifically expressed inmyeloid cells where it promotes phagocytosis whilst inhibiting cytokine production [115].”
BackgroundNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“[78] demonstrated a strong correlation between neuronal loss in the cerebral cortex and increased NFT burden with disease progression; no such correlation was found with Aβ.”
BackgroundAdult hippocampal neurogenesis buffers stress responses and depressive behaviour
Snyder, J. S., Soumier, A., Brewer, M., Pickel, J., & Cameron, H. A. (2011) · Nature · doi:10.1038/nature10287 · Cited by 1,473 · cited 1×
“In a vicious cycle, alteration in neurogenesis of adult brain is recently shown to impact on GC negative feedback on the central elements regulating HPA axis activity [65, 66].”
BackgroundOberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. (2008) · Epigenetics · doi:10.4161/epi.3.2.6034 · Cited by 1,432 · cited 1×
“Subsequently, similar mechanisms were reported in humans who had experienced childhood adversity [34] and in infants born to depressed mothers [35].”
BackgroundPropagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395 · cited 1×
“Moreover, a large number of studies have shown that stress and elevated GC levels affect neurogenesis in adult brain with subsequent impairments of mood and cognitive behavior [59, 60].”
BackgroundMechanisms of stress in the brain
McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., Karatsoreos, I. N., & Nasca, C. (2015) · Nature Neuroscience · doi:10.1038/nn.4086 · Cited by 1,386
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Adrenal steroid receptors and actions in the nervous system
McEwen, B. S., De Kloet, E. R., & Rostene, W. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.1121 · Cited by 1,232 · cited 1×
“Their actions are mediated by two receptors: the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR), which belong to the superfamily of nuclear receptors that act as transcription modulators [13, 14].”
BackgroundDynamic DNA methylation programs persistent adverse effects of early-life stress
Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmühl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F. X., & Spengler, D. (2009) · Nature Neuroscience · doi:10.1038/nn.2436 · Cited by 1,162 · cited 1×
“The earlier studies in rats were replicated in mice in paradigms of prenatal GC exposure and early postnatal stress; we showed that these pre- and postnatal manipulations resulted in epigenetic modifications of the promoters of neurotransmitter (dopamine receptor 2) [36], GR, and various GR target genes [37, 38] with…”
BackgroundSelf-citationRapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156 · cited 1×
“This would also implicate dopaminergic neurons in the ventral tegmentum area (VTA), which although relatively spared in PD are well-known to regulate reward and aversion by stress and have been implicated not only in addiction but also depression involving the transcriptional factor CREB and BDNF [138–141].”
BackgroundThe Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course
McEwen, B. S., & Morrison, J. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.028 · Cited by 1,079 · cited 1×
“Both vulnerability and resilience may be determined by genetic and epigenetic (gene environmental interactions) background [5–9].”
BackgroundDopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073 · cited 1×
“In fact, firing patterns of dopamine neurons in VTA correlated with depressive-like behaviors in mice, although the effect appears to depend on the stress paradigm used to induce the depressive-like behavior [139, 143].”
BackgroundThe biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
Glucocorticoids, prenatal stress and the programming of disease
Harris, A., & Seckl, J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.06.007 · Cited by 871 · cited 2×
“In addition to altering gene expression, growing evidence suggests that epigenetic mechanisms represent a means through which stress and GCs can leave longlasting “memories” of past experiences which, in turn, contributes to shaping the organism’s physical and mental health trajectory [21, 30, 31]; see Figure 1.”
BackgroundChronic Stress Causes Frontostriatal Reorganization and Affects Decision-Making
Dias-Ferreira, E., Sousa, J. C., Melo, I., Morgado, P., Mesquita, A. R., Cerqueira, J. J., Costa, R. M., & Sousa, N. (2009) · Science · doi:10.1126/science.1171203 · Cited by 858 · cited 1×
“Indeed, it has been shown that chronic stress leads to opposing structural changes in the limbic/associative and sensorimotor striatal circuitrywith atrophy in the former and hypertrophy of sensorimotor striatum, leading to habit behavior [135].”
BackgroundSelf-citationAn epigenetic blockade of cognitive functions in the neurodegenerating brain
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., et al. (2012) · Nature · doi:10.1038/nature10849 · Cited by 853 · cited 1×
“While most current research on epigenetic mechanisms focuses on DNAmethylation, one recent study demonstrated that GC, acting via GR, increase the levels of histone deacetylase 2 (HDAC2), an enzyme regulating DNA expression, in the CK-p25 mouse [41].”
BackgroundOwens, P. C., Smith, R., Brinsmead, M. W., Hall, C., Rowley, M., Hurt, D., Lovelock, M., Chan, E.-C., Cubis, J., & Lewin, T. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90603-5 · Cited by 847
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Prenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825 · cited 1×
“In addition to altering gene expression, growing evidence suggests that epigenetic mechanisms represent a means through which stress and GCs can leave longlasting “memories” of past experiences which, in turn, contributes to shaping the organism’s physical and mental health trajectory [21, 30, 31]; see Figure 1.”
BackgroundTau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Sex differences and stress across the lifespan
Bale, T. L., & Epperson, C. N. (2015) · Nature Neuroscience · doi:10.1038/nn.4112 · Cited by 751 · cited 1×
“Both vulnerability and resilience may be determined by genetic and epigenetic (gene environmental interactions) background [5–9].”
BackgroundStreit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727 · cited 1×
“Microglial dystrophy and fragmentation observed in aging brain [118] occur before the appearance of abnormal Tau suggesting dysfunctional microglia could contribute to appearance of Tau pathology.”
BackgroundParesce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663
Wohleb, E. S., Hanke, M. L., Corona, A. W., Powell, N. D., Stiner, L. M., Bailey, M. T., Nelson, R. J., Godbout, J. P., & Sheridan, J. F. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0450-11.2011 · Cited by 638
Glucocorticoids increase amyloid-β and tau pathology in a mouse model of alzheimer’s disease
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2797-06.2006 · Cited by 623
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
The prefrontal cortex as a key target of the maladaptive response to stress
Cerqueira, J. J., Mailliet, F., Almeida, O. F. X., Jay, T. M., & Sousa, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4372-06.2007 · Cited by 599 · cited 1×
“Here, it is also worthwhile noting that stress and GC interfere with hippocampal-prefrontal cortex (PFC) connectivity [68] and dendritic and synaptic plasticity in the PFC, thus disrupting executive functions [58].”
BackgroundSelf-citationBessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · cited 1×
“This brief review considers some of the cellular mechanisms through which stress and GC may contribute to the pathogenesis of AD and PD.”
BackgroundSelf-citationFetal programming of hypothalamo‐pituitary‐adrenal function: prenatal stress and glucocorticoids
Kapoor, A., Dunn, E., Kostaki, A., Andrews, M. H., & Matthews, S. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105254 · Cited by 598 · cited 1×
“There is now abundant evidence that GCs can exert profoundmodulatory effects on a variety of brain functions from early development through to late life [12].”
BackgroundGlucocorticoids and fetal programming part 1: outcomes
Moisiadis, V. G., & Matthews, S. G. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.73 · Cited by 576
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Tu, S., Okamoto, S.-I., Lipton, S. A., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-48 · Cited by 576
Variations in maternal care in infancy regulate the development of stress reactivity
Caldji, C., Diorio, J., & Meaney, M. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01084-2 · Cited by 574 · cited 1×
“The first evidence of epigenetic programing in the brain by early life adversity showed that poor maternal care in rats leads to methylation of exon 1 7 in the GR promoter, being accompanied by aberrant behaviors and altered HPA axis responses during adulthood [32, 33].”
BackgroundCaspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543 · cited 1×
“This truncation-dependent misfolding of Tau into an abnormal conformation is known to facilitate nucleation and recruitment of other Tau molecules into neurotoxic aggregates [95, 96] before NFT are formed [95, 97, 98].”
BackgroundWork Stress as a Risk Factor for Cardiovascular Disease
Kivimäki, M., & Kawachi, I. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0630-8 · Cited by 518 · cited 1×
“and mental disorders [2–5].”
Human innate immunosenescence: causes and consequences for immunity in old age
Panda, A., Arjona, A., Sapey, E., Bai, F., Fikrig, E., Montgomery, R. R., Lord, J. M., & Shaw, A. C. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.004 · Cited by 502 · cited 1×
“Immune-regulatory processes are compromised in aging (immunosenescence) and also during chronic stress [161] where there is an increased susceptibility to infections as well as proinflammatory cytokine production [162].”
BackgroundTau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486
Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience
Friedman, A. K., Walsh, J. J., Juarez, B., Ku, S. M., Chaudhury, D., Wang, J., Li, X., Dietz, D. M., Pan, N., Vialou, V. F., et al. (2014) · Science · doi:10.1126/science.1249240 · Cited by 484 · cited 1×
“In fact, firing patterns of dopamine neurons in VTA correlated with depressive-like behaviors in mice, although the effect appears to depend on the stress paradigm used to induce the depressive-like behavior [139, 143].”
BackgroundKrabbe, G., Halle, A., Matyash, V., Rinnenthal, J. L., Eom, G. D., Bernhardt, U., Miller, K. R., Prokop, S., Kettenmann, H., & Heppner, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060921 · Cited by 478
Toward understanding how early-life stress reprograms cognitive and emotional brain networks
Chen, Y., & Baram, T. Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.181 · Cited by 474 · cited 1×
“However, a growing body of evidence suggests that high GC exposure in early life can adversely program the HPA axis and increase the susceptibility to develop metabolic, neuropsychiatric, and neurodegenerative disorders [5, 20, 21].”
BackgroundBanasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Glucocorticoids and fetal programming part 2: mechanisms
Moisiadis, V. G., & Matthews, S. G. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.74 · Cited by 449 · cited 1×
“In addition to altering gene expression, growing evidence suggests that epigenetic mechanisms represent a means through which stress and GCs can leave longlasting “memories” of past experiences which, in turn, contributes to shaping the organism’s physical and mental health trajectory [21, 30, 31]; see Figure 1.”
BackgroundMicroglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism
Koenigsknecht, J., & Landreth, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2557-04.2004 · Cited by 446
Lucassen, P. J., Pruessner, J., Sousa, N., Almeida, O. F. X., Van Dam, A. M., Rajkowska, G., Swaab, D. F., & Czéh, B. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1223-5 · Cited by 441 · cited 2×
“Here, it is also worthwhile noting that stress and GC interfere with hippocampal-prefrontal cortex (PFC) connectivity [68] and dendritic and synaptic plasticity in the PFC, thus disrupting executive functions [58].”
BackgroundSelf-citationGhosh, A., Roy, A., Liu, X., Kordower, J. H., Mufson, E. J., Hartley, D. M., Ghosh, S., Mosley, R. L., Gendelman, H. E., & Pahan, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704908104 · Cited by 438
Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk
Mayeux, R., Honig, L. S., Tang, M.-X., Manly, J., Stern, Y., Schupf, N., & Mehta, P. D. (2003) · Neurology · doi:10.1212/01.wnl.0000091890.32140.8f · Cited by 434
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 426
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2164 · Cited by 426 · cited 1×
“The potential link between stress/GC and AD described above is strengthened by emerging evidence that stress may advance the age of onset of the familial formofAD [47, 48, 55] and that cortisol levels in AD patients correlate with their memory deficits [56, 57] suggesting a role for GC on AD.”
BackgroundPlasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2164 · Cited by 426
Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I. M., & De Bosscher, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.014 · Cited by 411
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
Kempster, P. A., O'Sullivan, S. S., Holton, J. L., Revesz, T., & Lees, A. J. (2010) · Brain · doi:10.1093/brain/awq059 · Cited by 410
Neuropathology of Autonomic Nervous System in Parkinson's Disease
Wakabayashi, K., & Takahashi, H. (1997) · European Neurology · doi:10.1159/000113469 · Cited by 407 · cited 1×
“PD is believed to originate from olfactory nucleus and autonomic nervous system progressing in an ascending manner to many brain regions such as substantia nigra, striatum, raphe, locus coeruleus, hypothalamic nuclei, hippocampus, amygdala, and cerebral cortex accounting for both motor and nonmotor symptoms [121–123].”
BackgroundTynan, R. J., Weidenhofer, J., Hinwood, M., Cairns, M. J., Day, T. A., & Walker, F. R. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.12.011 · Cited by 386
Rapp, M. A., Schnaider-Beeri, M., Grossman, H. T., Sano, M., Perl, D. P., Purohit, D. P., Gorman, J. M., & Haroutunian, V. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.161 · Cited by 386 · cited 1×
“In light of the increasing volume of data implicating high GC levels in AD, it is important to consider that epidemiological studies implicate depression as a risk factor for the development of AD; this is supported by the observation that previously depressed subjects have increased amyloid plaque and NFT loads [100].”
ResultKurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · cited 1×
“The synthetic analogue of GCs, dexamethasone, was shown to attenuate dopamine neuronal loss by precluding activated microglia from releasing toxic inflammatory molecules [157, 158].”
BackgroundFrancis, T. C., Chandra, R., Friend, D. M., Finkel, E., Dayrit, G., Miranda, J., Brooks, J. M., Iñiguez, S. D., O’Donnell, P., Kravitz, A., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.021 · Cited by 379 · cited 1×
“Electrophysiological evidence implicates changes in both D1R and D2R-medium spiny neurons (MSNs) in the ventral striatum [144], but the depressive-behaviors seems to preferentially affect D1R MSNs [145] (Figure 3).”
BackgroundUltradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription
Stavreva, D. A., Wiench, M., John, S., Conway-Campbell, B. L., McKenna, M. A., Pooley, J. R., Johnson, T. A., Voss, T. C., Lightman, S. L., & Hager, G. L. (2009) · Nature Cell Biology · doi:10.1038/ncb1922 · Cited by 375 · cited 1×
“Upon GC binding, conformational change of the GR-chaperone complex results in nuclear translocation of the GR [24, 25].”
BackgroundAnhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens
Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11160 · Cited by 368
Premotor and nonmotor features of Parkinson's disease
Goldman, J. G., & Postuma, R. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000112 · Cited by 343 · cited 2×
“Interestingly, there is also evidence in PD for lower novelty-seeking and high harm avoidance personality traits with anxiety-associated symptoms [43, 137].”
BackgroundThe importance of inflammatory mechanisms in alzheimer disease
McGeer, E. G., & McGeer, P. L. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00013-8 · Cited by 335
Tavares, R. G., Tasca, C. I., Santos, C. E. S., Alves, L. B., Porciúncula, L. O., Emanuelli, T., & Souza, D. O. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00133-4 · Cited by 320 · cited 1×
“Quinolinic acid toxicity with increased glutamate release results in lipid peroxidation and nitrative stress [168, 169] Evidence shows that the kynurenic acid/tryptophan ratio is altered in CSF and serum in PD patients [170].”
BackgroundHartmann, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80309-0 · Cited by 318 · cited 2×
“In fact, high levels of cortisol are commonly found in AD patients’ plasma, saliva, and/or CSF [49–53]; AD patients also show higher total daily secretion of cortisol [54].”
BackgroundInvolvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R., Anisman, H., Hayley, S., & Park, D. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 315
Conformational change as one of the earliest alterations of tau in Alzheimer's disease
Weaver, C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00157-3 · Cited by 310 · cited 1×
“This truncation-dependent misfolding of Tau into an abnormal conformation is known to facilitate nucleation and recruitment of other Tau molecules into neurotoxic aggregates [95, 96] before NFT are formed [95, 97, 98].”
BackgroundMechanisms of glucocorticoid signalling
Schoneveld, O. J. L. M., Gaemers, I. C., & Lamers, W. H. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.09.004 · Cited by 310
Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses
Frank, M. G., Thompson, B. M., Watkins, L. R., & Maier, S. F. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.005 · Cited by 310 · cited 1×
“Importantly, subsequent inflammatory or toxic stimuli result in aggravation of neuronal injury [119, 120, 163].”
BackgroundZunszain, P. A., Hepgul, N., & Pariante, C. M. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_211 · Cited by 303
Microglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291 · cited 1×
“Inflammation and AD: Role of GCs? Chronic inflammation is one of the central pathological features of AD with reactive microglia and astrocytes surrounding senile β-amyloid plaques observed in both postmortem AD brain and animal models [107, 108].”
BackgroundRoselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M., & Almeida, O. F. X. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 277
Self-citationNeurodegeneration and Inflammation in Parkinson's disease
Phani, S., Loike, J. D., & Przedborski, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70064-5 · Cited by 263 · cited 1×
“In line with observations in PD patients, presence of inflammatory mediators and glial reactivity in striatum and substantia nigra is a key feature inmany of the experimental animal models of PD [150].”
BackgroundSotiropoulos, I., Catania, C., Pinto, L. G., Silva, R., Pollerberg, G. E., Takashima, A., Sousa, N., & Almeida, O. F. X. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0730-11.2011 · Cited by 257 · cited 3×
“Here, it is also worthwhile noting that stress and GC interfere with hippocampal-prefrontal cortex (PFC) connectivity [68] and dendritic and synaptic plasticity in the PFC, thus disrupting executive functions [58].”
BackgroundSelf-citationEarly-Life Risk Factors for Alzheimer Disease
Borenstein, A. R., Copenhaver, C. I., & Mortimer, J. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201854.62116.d7 · Cited by 257 · cited 1×
“, intrauterine infections, maternal stress, and poor maternal and perinatal nutrition) may play a role in the onset of Alzheimer’s disease (AD), an age-related neurodegenerative disorder characterized progressive memory and cognitive deficits [39].”
BackgroundMcEwen, B. S., Gray, J. D., & Nasca, C. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0121 · Cited by 253
Carroll, J. C., Iba, M., Bangasser, D. A., Valentino, R. J., James, M. J., Brunden, K. R., Lee, V. M.-Y., & Trojanowski, J. Q. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3836-11.2011 · Cited by 251 · cited 1×
“On the other hand, some studies have suggested a role for at least one other stress-related molecule, namely, corticotrophinreleasing hormone (CRH), as deletion of the CRH receptor 1 gene in mice was found to block the detrimental effects of stress on Tau phosphorylation [92, 93].”
BackgroundDopamine‐related personality traits in Parkinson's disease
Menza, M. A., Golbe, L. I., Cody, R. A., & Forman, N. E. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.505 · Cited by 247 · cited 1×
“Interestingly, there is also evidence in PD for lower novelty-seeking and high harm avoidance personality traits with anxiety-associated symptoms [43, 137].”
BackgroundCastaño, A., Herrera, A. J., Cano, J., & Machado, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 238
Jeong, Y. H., Park, C. H., Yoo, J., Shin, K. Y., Ahn, S., Kim, H., Lee, S. H., Emson, P. C., & Suh, Y. (2006) · The FASEB Journal · doi:10.1096/fj.05-4265fje · Cited by 238
Ahima, R., Krozowski, Z., & Harlan, R. E. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130312 · Cited by 232 · cited 1×
“MR is also present in nonneuronal cells, namely, in glia and epithelial cells of the choroid plexus and ependyma [15].”
BackgroundOomen, C. A., Mayer, J. L., De Kloet, E. R., Joëls, M., & Lucassen, P. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05972.x · Cited by 232 · cited 1×
“In addition, administration of corticosterone showed the ability of glucocorticoids to damage neurogenesis in adult brain by inhibiting cell proliferation, differentiation and survival [63] while the deleterious effect of stress and/or corticosterone on neurogenesis is GC-dependent [64].”
BackgroundRos-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · cited 4×
“Specifically, previous studies [54, 126–128] including our ownwork [129] show that plasma cortisol levels are significantly higher in idiopathic PD patients compared to control subjects; however, these high levels do not correlate to disease duration or to L-3,4-dihydroxyphenylalanine (L-DOPA) treatment.”
BackgroundResultInfluentialSelf-citationAPOE genotype alters glial activation and loss of synaptic markers in mice
Zhu, Y., Nwabuisi‐Heath, E., Dumanis, S. B., Tai, L. M., Yu, C., Rebeck, G. W., & Ladu, M. J. (2012) · Glia · doi:10.1002/glia.22289 · Cited by 224 · cited 1×
“APOE is produced by both microglia and astrocytes; it regulates not only lipid and Aβmetabolism but also microglial chemotaxis and proinflammatory cytokine expression [114].”
BackgroundAn Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice
Sheline, Y. I., West, T., Yarasheski, K., Swarm, R., Jasielec, M. S., Fisher, J. R., Ficker, W. D., Yan, P., Xiong, C., Frederiksen, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008169 · Cited by 223
Inflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222 · cited 2×
“A number of susceptibility loci identified relate to genes expressed in immune cells such as HLA-DQB1, LRRK2 or BST-1 [151, 152].”
BackgroundIannaccone, S., Cerami, C., Alessio, M., Garibotto, V., Panzacchi, A., Olivieri, S., Gelsomino, G., Moresco, R. M., & Perani, D. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.002 · Cited by 221 · cited 1×
“radiolabeled ligand (11)C-PK-11195 for translocator protein, Positron Emission Tomography (PET) studies in PD patients revealed an early activation of microglia in many brain regions including basal ganglia and midbrain [147, 148].”
BackgroundStress increases vulnerability to inflammation in the rat prefrontal cortex
de Pablos, R. M., Villarán, R. F., Argüelles, S., Herrera, A. J., Venero, J. L., Ayala, A., Cano, J., & Machado, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-06.2006 · Cited by 215
Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons
Barik, J., Marti, F., Morel, C., Fernandez, S. P., Lanteri, C., Godeheu, G., Tassin, J.-P., Mombereau, C., Faure, P., & Tronche, F. (2013) · Science · doi:10.1126/science.1226767 · Cited by 214 · cited 1×
“This would also implicate dopaminergic neurons in the ventral tegmentum area (VTA), which although relatively spared in PD are well-known to regulate reward and aversion by stress and have been implicated not only in addiction but also depression involving the transcriptional factor CREB and BDNF [138–141].”
BackgroundSelf-citationSpecificity of the Adrenal Steroid Receptor System in Rat Hippocampus*
VELDHUIS, H. D., VAN KOPPEN, C., VAN ITTERSUM, M., & DE KLOET, R. E. (1982) · Endocrinology · doi:10.1210/endo-110-6-2044 · Cited by 210 · cited 1×
“Their actions are mediated by two receptors: the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR), which belong to the superfamily of nuclear receptors that act as transcription modulators [13, 14].”
BackgroundMolecular mechanisms in the regulation of adult neurogenesis during stress
Egeland, M., Zunszain, P. A., & Pariante, C. M. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3855 · Cited by 203 · cited 1×
“Moreover, a large number of studies have shown that stress and elevated GC levels affect neurogenesis in adult brain with subsequent impairments of mood and cognitive behavior [59, 60].”
BackgroundWang, Y. P., Biernat, J., Pickhardt, M., Mandelkow, E., & Mandelkow, E.-M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703676104 · Cited by 202 · cited 1×
“This truncation-dependent misfolding of Tau into an abnormal conformation is known to facilitate nucleation and recruitment of other Tau molecules into neurotoxic aggregates [95, 96] before NFT are formed [95, 97, 98].”
BackgroundWong, E. Y. H., & Herbert, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.073 · Cited by 200 · cited 1×
“In addition, administration of corticosterone showed the ability of glucocorticoids to damage neurogenesis in adult brain by inhibiting cell proliferation, differentiation and survival [63] while the deleterious effect of stress and/or corticosterone on neurogenesis is GC-dependent [64].”
BackgroundAdverse Stress, Hippocampal Networks, and Alzheimer’s Disease
Rothman, S. M., & Mattson, M. P. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8107-9 · Cited by 198 · cited 1×
“The potential link between stress/GC and AD described above is strengthened by emerging evidence that stress may advance the age of onset of the familial formofAD [47, 48, 55] and that cortisol levels in AD patients correlate with their memory deficits [56, 57] suggesting a role for GC on AD.”
BackgroundCSF biomarkers for mild cognitive impairment and early Alzheimer's disease
Andreasen, N., & Blennow, K. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.10.011 · Cited by 193 · cited 1×
“Different studies have in fact sought to discriminate between subjects undergoing normal aging from those suffering from depression or AD through the measurement of the various APP cleavage products [101–104].”
BackgroundQureshi, S. U., Kimbrell, T., Pyne, J. M., Magruder, K. M., Hudson, T. J., Petersen, N. J., Yu, H., Schulz, P. E., & Kunik, M. E. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02977.x · Cited by 191 · cited 1×
“Lastly, it deserves mentioning that a recent epidemiological study found that the prevalence and incidence of dementia in war veterans suffering from posttraumatic depression (PTSD) is twice as high as that in age-matched PTSD-free subjects [106].”
ResultSuppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response
Schloesser, R. J., Manji, H. K., & Martinowich, K. (2009) · NeuroReport · doi:10.1097/wnr.0b013e3283293e59 · Cited by 188 · cited 1×
“This brief review considers some of the cellular mechanisms through which stress and GC may contribute to the pathogenesis of AD and PD.”
BackgroundPathology associated with sporadic Parkinson’s disease — where does it end?
Braak, H., Müller, C. M., Rüb, U., Ackermann, H., Bratzke, H., de Vos, R. A. I., & Del Tredici, K. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_15 · Cited by 182
The amyloidogenic potential and behavioral correlates of stress
Catania, C., Sotiropoulos, I., Silva, R., Onofri, C., Breen, K. C., Sousa, N., & Almeida, O. F. X. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002101 · Cited by 176 · cited 3×
“Further experiments that attempted to mimic intermittent stressful events thatmay exert cumulative effects over the lifetime indicated that GC potentiate the APP misprocessing pathway in previously stressed rats receiving A𝛽-infusions [83] (see Figure 2).”
BackgroundResultInfluentialSelf-citationHampel, H., Bürger, K., Pruessner, J. C., Zinkowski, R., DeBernardis, J., Kerkman, D., Leinsinger, G., Evans, A. C., Davies, P., Möller, H.-J., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.770 · Cited by 175
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?
Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174
Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
Widner, B., Leblhuber, F., & Fuchs, D. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200014 · Cited by 171 · cited 1×
“Quinolinic acid toxicity with increased glutamate release results in lipid peroxidation and nitrative stress [168, 169] Evidence shows that the kynurenic acid/tryptophan ratio is altered in CSF and serum in PD patients [170].”
BackgroundIncreased CSF cortisol in AD is a function of APOE genotype
Peskind, E. R., Wilkinson, C. W., Petrie, E. C., Schellenberg, G. D., & Raskind, M. A. (2001) · Neurology · doi:10.1212/wnl.56.8.1094 · Cited by 171
Munhoz, C. D., Sorrells, S. F., Caso, J. R., Scavone, C., & Sapolsky, R. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0303-09.2010 · Cited by 169
Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
Vossel, K. A., Xu, J. C., Fomenko, V., Miyamoto, T., Suberbielle, E., Knox, J. A., Ho, K., Kim, D. H., Yu, G.-Q., & Mucke, L. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201407065 · Cited by 167
Lucassen, P. J., Oomen, C. A., Naninck, E. F. G., Fitzsimons, C. P., van Dam, A.-M., Czeh, B., & Korosi, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021303 · Cited by 166
Stein-Behrens, B., Elliott, E. M., Miller, C. A., Schilling, J. W., Newcombe, R. G., & Sapolsky, R. M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10047.x · Cited by 164 · cited 1×
“[84] who demonstrated that GC exacerbate kainic acidinduced hippocampal neuronal loss with a contemporaneous increase in Tau immunoreactivity.”
BackgroundThe Role of Stress Factors during Aging of the Immune System
Bauer, M. E., Jeckel, C. M. M., & Luz, C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03966.x · Cited by 164 · cited 1×
“Immune-regulatory processes are compromised in aging (immunosenescence) and also during chronic stress [161] where there is an increased susceptibility to infections as well as proinflammatory cytokine production [162].”
BackgroundCarvey, P. M. (2003) · Frontiers in Bioscience · doi:10.2741/1158 · Cited by 161 · cited 1×
“Since loss of dopaminergic neurons as well as related motor deficits is a characteristic feature of PD pathology, the above findings suggest that high LPS levels in mothers might interfere with the development of DA neurons in the fetus, thus enhancing susceptibility to PD [45].”
BackgroundNeurogenesis in Alzheimer’s disease: Neurogenesis in AD
Rodríguez, J. J., & Verkhratsky, A. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01343.x · Cited by 161 · cited 1×
“Moreover, perturbations in adult neurogenesis may also be related to the cognitive deficits associated with AD whereas contradictory findings support both increases and decreases of neurogenesis in brain of AD patients and Tg animal models [67].”
ResultCentral corticosteroid actions: Search for gene targets
Datson, N. A., Morsink, M. C., Meijer, O. C., & de Kloet, E. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.070 · Cited by 161 · cited 1×
“Nevertheless, transcriptomic studies in the hippocampus have identified functional classes of GR target genes which include genes coding for neurotransmitter catabolism, neurotrophic factors and their receptors, signal transduction, energy metabolism, and cell adhesion [29].”
BackgroundMulticenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
Ewers, M., Büerger, K., Teipel, S. J., Scheltens, P., Schröder, J., Zinkowski, R. P., Bouwman, F. H., Schönknecht, P., Schoonenboom, N. S. M., Andreasen, N. C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000286944.22262.ff · Cited by 161 · cited 1×
“Here, it is pertinent to note that the extent of phosphorylation at Thr231- and Ser262-Tau correlates strongly with severity of memory impairment, speed of mental processing, and executive functioning in AD patients [89–91].”
BackgroundCognitive Dysfunction, Hippocampal Atrophy and Glucocorticoid Feedback in Alzheimer’s Disease
Elgh, E., Lindqvist Åstot, A., Fagerlund, M., Eriksson, S., Olsson, T., & Näsman, B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.017 · Cited by 159 · cited 1×
“The potential link between stress/GC and AD described above is strengthened by emerging evidence that stress may advance the age of onset of the familial formofAD [47, 48, 55] and that cortisol levels in AD patients correlate with their memory deficits [56, 57] suggesting a role for GC on AD.”
BackgroundDisconnection and reconnection: The morphological basis of (mal)adaptation to stress
Sousa, N., & Almeida, O. F. X. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.006 · Cited by 159 · cited 2×
“Indeed, previous studies from our laboratories (and others) have shown that hippocampal neurons are particularly vulnerable to the adverse effects of stress and GC, their effects being manifested as dendritic atrophy and apoptotic cell death [22, 58].”
BackgroundSelf-citationKidney development and the fetal programming of adult disease
Moritz, K. M., Dodic, M., & Wintour, E. M. (2003) · BioEssays · doi:10.1002/bies.10240 · Cited by 158 · cited 1×
“, emotion, cognition, and motor) processes [1, 10–12].”
Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation
Rissman, R. A., Lee, K., Vale, W., & Sawchenko, P. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5173-06.2007 · Cited by 156 · cited 1×
“On the other hand, some studies have suggested a role for at least one other stress-related molecule, namely, corticotrophinreleasing hormone (CRH), as deletion of the CRH receptor 1 gene in mice was found to block the detrimental effects of stress on Tau phosphorylation [92, 93].”
BackgroundFuruya, T., Hayakawa, H., YAMADA, M., Yoshimi, K., Hisahara, S., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3309-03.2004 · Cited by 153
GREENWALD, B. S., Mathé, A. A., Mohs, R. C., Levy, M. I., Johns, C. A., & Davis, K. L. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.442 · Cited by 150 · cited 1×
“…Pierre et Marie Curie, Paris Cedex 05, France 2Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 3ICVS/3B’s-PT Government Associate Laboratory, Guimarães, Braga, Portugal 4Max Planck Institute…”
BackgroundThe dynamics of the stress neuromatrix
Sousa, N. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.196 · Cited by 142 · cited 1×
“Both vulnerability and resilience may be determined by genetic and epigenetic (gene environmental interactions) background [5–9].”
BackgroundSelf-citationStress effects on the neural substrates of motivated behavior
Hollon, N. G., Burgeno, L. M., & Phillips, P. E. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4114 · Cited by 140 · cited 1×
“Electrophysiological evidence implicates changes in both D1R and D2R-medium spiny neurons (MSNs) in the ventral striatum [144], but the depressive-behaviors seems to preferentially affect D1R MSNs [145] (Figure 3).”
BackgroundCSF tau markers are correlated with hippocampal volume in Alzheimer's disease
de Souza, L. C., Marie Chupin, A., Lamari, F., Jardel, C., Leclercq, D., Olivier Colliot, A., Lehéricy, S., Dubois, B., & Sarazin, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.022 · Cited by 140
Distinct Representations of Cognitive and Motivational Signals in Midbrain Dopamine Neurons
Matsumoto, M., & Takada, M. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.002 · Cited by 135
Stypuła, G., Radek, M., Stepien, H., Żylińska, K., & Pawlikowski, M. (1996) · NeuroImmunoModulation · doi:10.1159/000097237 · Cited by 134 · cited 1×
“Specifically, previous studies [54, 126–128] including our ownwork [129] show that plasma cortisol levels are significantly higher in idiopathic PD patients compared to control subjects; however, these high levels do not correlate to disease duration or to L-3,4-dihydroxyphenylalanine (L-DOPA) treatment.”
ResultMicroglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
Mhatre, S. D., Tsai, C. A., Rubin, A. J., James, M. L., & Andreasson, K. I. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.006 · Cited by 134 · cited 2×
“Recent genome-wide association studies have identified variants in at least 16 genes involved in microglia/macrophage functions as risks for developing AD [113].”
BackgroundBockmühl, Y., Patchev, A. V., Madejska, A., Hoffmann, A., Sousa, J. C., Sousa, N., Holsboer, F., Almeida, O. F. X., & Spengler, D. (2015) · Epigenetics · doi:10.1080/15592294.2015.1017199 · Cited by 133 · cited 1×
“The earlier studies in rats were replicated in mice in paradigms of prenatal GC exposure and early postnatal stress; we showed that these pre- and postnatal manipulations resulted in epigenetic modifications of the promoters of neurotransmitter (dopamine receptor 2) [36], GR, and various GR target genes [37, 38] with…”
BackgroundSelf-citationMicroglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia
Olsson, B., Hertze, J., Lautner, R., Zetterberg, H., Nägga, K., Höglund, K., Basun, H., Annas, P., Lannfelt, L., Andreasen, N., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120787 · Cited by 132 · cited 1×
“Evidence from human studies suggests that glial activation is an early event; thus inflammatory markers are present in mild cognitive impairment cases that eventually progress to AD [109].”
BackgroundStress‐induced neurological impairments in an animal model of parkinsonism
Snyder, A. M., Stricker, E. M., & Zigmond, M. J. (1985) · Annals of Neurology · doi:10.1002/ana.410180506 · Cited by 128 · cited 1×
“The role of stress in PD is supported by few experimental studies such as food deprivation and tail-shock and maternal separation aggravate motor deficits in the 6-hydroxydopamine (6-OHDA) PD model (6hydroxydopamine local injections lesions the nigrostriatal pathway) [133].”
BackgroundStress as a Modulator of Motor System Function and Pathology
Metz, G. A. S. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.3-4.209 · Cited by 127 · cited 1×
“Indeed, the role of stress was proposed as one of the underlying causes of PD as clinical reports show that stress triggers the appearance of PD symptoms or exacerbates the motor symptoms [130–132].”
BackgroundHypothalamic-pituitary-adrenal system function in patients with alzheimer's disease
Hatzinger, M., Z'Brun, A., Hemmeter, U., Seifritz, E., Baumann, F., Holsboer‐Trachsler, E., & Heuser, I. J. E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00159-6 · Cited by 126
Stress-induced Parkinson's disease: a working hypothesis
SMITH, A., Castro, S., & Zigmond, M. J. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00939-3 · Cited by 122 · cited 1×
“In combined chronic stress exposure with 6-OHDA lesion, stress was shown to worsen the 6-OHDAdriven motor deficits, aggravate the neurodegeneration of nigrostriatal system, and completely block compensatory recovery of motor tasks [131, 134].”
BackgroundSupportive evidence for 11 loci from genome-wide association studies in Parkinson's disease
Pihlstrøm, L., Axelsson, G., Bjørnarå, K. A., Dizdar, N., Fardell, C., Forsgren, L., Holmberg, B., Larsen, J. P., Linder, J., Nissbrandt, H., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.019 · Cited by 120 · cited 2×
“A number of susceptibility loci identified relate to genes expressed in immune cells such as HLA-DQB1, LRRK2 or BST-1 [151, 152].”
BackgroundCSF biomarkers in relationship to cognitive profiles in Alzheimer disease
van der Vlies, A. E., Verwey, N. A., Bouwman, F. H., Blankenstein, M. A., Klein, M., Scheltens, P., & van der Flier, W. M. (2009) · Neurology · doi:10.1212/01.wnl.0000345014.48839.71 · Cited by 118
Rasmuson, S., Andrew, R., Näsman, B., Seckl, J. R., Walker, B. R., & Olsson, T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01015-5 · Cited by 112 · cited 2×
“…et Marie Curie, Paris Cedex 05, France 2Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 3ICVS/3B’s-PT Government Associate Laboratory, Guimarães, Braga, Portugal 4Max Planck Institute of…”
BackgroundObradovic, D., Tirard, M., Némethy, Z., Hirsch, O., Gronemeyer, H., & Almeida, O. F. X. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.761 · Cited by 104
Self-citationCortisol is higher in parkinsonism and associated with gait deficit
Charlett, A., Dobbs, R. J., Purkiss, A. G., Wrighe, D. J., Peterson, D. W., Weller, C., & Dobbs, S. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00614.x · Cited by 102
Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease.
Sotiropoulos, I., Cerqueira, J., Catania, C., Takashima, A., Sousa, N., & Almeida, O. (2008) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.007 · Cited by 100 · cited 1×
“Both vulnerability and resilience may be determined by genetic and epigenetic (gene environmental interactions) background [5–9].”
BackgroundSelf-citationSotiropoulos, I., Catania, C., Riedemann, T., Fry, J. P., Breen, K. C., Michaelidis, T. M., & Almeida, O. F. X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05613.x · Cited by 97 · cited 4×
“Similar findings were obtained in vivo when young (prodromal) 3XTg-AD mice were treated with the synthetic GC, dexamethasone [80]; the same authors also reported dexamethasone-induced APPmisprocessing in the N2A cell line, a findingmatched by our own observations in PC12 cells [82].”
BackgroundResultInfluentialSelf-citationFaa, G., Marcialis, M., Ravarino, A., Piras, M., Pintus, M., & Fanos, V. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140601163658 · Cited by 85
Quinolinic acid: neurotoxicity
Guillemin, G. J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08493.x · Cited by 83 · cited 1×
“Quinolinic acid toxicity with increased glutamate release results in lipid peroxidation and nitrative stress [168, 169] Evidence shows that the kynurenic acid/tryptophan ratio is altered in CSF and serum in PD patients [170].”
BackgroundNongenetic Factors as Modifiers of the Age of Onset of Familial Alzheimer’s Disease
Mejía-Arango, S., Giraldo, M., Pineda, D. A., Lopera, F. J., & Ardila, A. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203009591 · Cited by 82 · cited 2×
“stress in adulthood as well as elevated GC levels may have a role in the development of AD pathology and related dementia [47, 48].”
BackgroundRussell, G. M., Kalafatakis, K., & Lightman, S. L. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12247 · Cited by 79 · cited 1×
“Upon GC binding, conformational change of the GR-chaperone complex results in nuclear translocation of the GR [24, 25].”
BackgroundGestational Restraint Stress and the Developing Dopaminergic System: An Overview
Baier, C. J., Katunar, M. R., Adrover, E., Pallarés, M. E., & Antonelli, M. C. (2012) · Neurotoxicity Research · doi:10.1007/s12640-011-9305-4 · Cited by 79 · cited 1×
“Accordingly, developmental stress may represent the first imprint in the brain and accumulatively with later stressful stimuli to affect nigrostriatal neurochemical reserve and precipitate the PD phenotype [46].”
BackgroundMorais, M., Santos, P. A., Mateus‐Pinheiro, A., Patrício, P., Pinto, L., Sousa, N., Pedroso, P., Almeida, S., Filipe, A., & Bessa, J. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114553646 · Cited by 79 · cited 1×
“This brief review considers some of the cellular mechanisms through which stress and GC may contribute to the pathogenesis of AD and PD.”
BackgroundSelf-citationStress exacerbates experimental Parkinson’s disease
Hemmerle, A. M., Dickerson, J. W., Herman, J. P., & Seroogy, K. B. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.108 · Cited by 75 · cited 1×
“In combined chronic stress exposure with 6-OHDA lesion, stress was shown to worsen the 6-OHDAdriven motor deficits, aggravate the neurodegeneration of nigrostriatal system, and completely block compensatory recovery of motor tasks [131, 134].”
BackgroundComparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles
Lauckner, J., Frey, P., & Geula, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00228-2 · Cited by 72 · cited 1×
“, pSer262) [86, 87] and hippocampal atrophy (e.”
Rodrigues, A. J., Leão, P., Pêgo, J. M., Cardona, D., Carvalho, M. M., de Oliveira, M. M., Costa, B. M., Carvalho, A. F., Morgado, P. F., Araújo, D., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.126 · Cited by 69 · cited 1×
“The earlier studies in rats were replicated in mice in paradigms of prenatal GC exposure and early postnatal stress; we showed that these pre- and postnatal manipulations resulted in epigenetic modifications of the promoters of neurotransmitter (dopamine receptor 2) [36], GR, and various GR target genes [37, 38] with…”
BackgroundSelf-citationProgressive Reduction of Synaptophysin Message in Single Neurons in Alzheimer Disease
Callahan, L. M., Vaules, W. A., & Coleman, P. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.384 · Cited by 67 · cited 1×
“, pSer262) [86, 87] and hippocampal atrophy (e.”
Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression
Hoogendijk, W. J. G., Meynen, G., Endert, E., Hofman, M. A., & Swaab, D. F. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.017 · Cited by 64 · cited 2×
“…Curie, Paris Cedex 05, France 2Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 3ICVS/3B’s-PT Government Associate Laboratory, Guimarães, Braga, Portugal 4Max Planck Institute of Psychiatry,…”
BackgroundPsychological distress and risk for dementia
Simard, M., Hudon, C., & van Reekum, R. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0007-z · Cited by 62 · cited 2×
“stress in adulthood as well as elevated GC levels may have a role in the development of AD pathology and related dementia [47, 48].”
BackgroundTranscriptional Regulation of Perinatal Lung Maturation
Whitsett, J. A., & Matsuzaki, Y. (2006) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2006.08.009 · Cited by 60 · cited 1×
“, emotion, cognition, and motor) processes [1, 10–12].”
Martišová, E., Aisa, B., Gereñu, G., & Ramírez, M. J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040007 · Cited by 52
Sotiropoulos, I., Silva, J. M., Kimura, T., Rodrigues, A. J., Costa, P., Almeida, O. F. X., Sousa, N., & Takashima, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140693 · Cited by 43 · cited 2×
“, Hsp90 and Hsp70) that are responsible for Tau proteostasis [94] (see Figure 2).”
BackgroundSelf-citationNon-receptor-tyrosine Kinases Integrate Fast Glucocorticoid Signaling in Hippocampal Neurons
Yang, S., Roselli, F., Patchev, A. V., Yu, S., & Almeida, O. F. X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470146 · Cited by 41 · cited 1×
“In addition to nongenomic mechanisms that are still incompletely identified [23], chronic stress and GC levels most likely influence neuronal function and connectivity by activating GR-mediated transcription.”
BackgroundSelf-citationPienaar, I. S., Kellaway, L. A., Russell, V. A., Smith, A. D., Stein, D. J., Zigmond, M. J., & Daniels, W. M. U. (2008) · Stress · doi:10.1080/10253890801890721 · Cited by 40 · cited 1×
“Maternal separation was reported to exacerbate motor deficits and nigrostriatal lesion in an experimental model of PD [44].”
BackgroundCortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia
Rabey, J. M., Scharf, M., Oberman, Z., Zohar, M., & Graff, E. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90525-7 · Cited by 38 · cited 1×
“Specifically, previous studies [54, 126–128] including our ownwork [129] show that plasma cortisol levels are significantly higher in idiopathic PD patients compared to control subjects; however, these high levels do not correlate to disease duration or to L-3,4-dihydroxyphenylalanine (L-DOPA) treatment.”
ResultTirard, M., Jasbinsek, J., Almeida, O. F. X., & Michaelidis, T. M. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320825 · Cited by 38 · cited 1×
“Moreover, evidence suggests that their cellular responses through regulation of distinct gene expression (as homodimers) depend strongly upon specific recruitment of coregulators [18, 19].”
BackgroundSelf-citationGoodman, J., Leong, K.-C., & Packard, M. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.014 · Cited by 35 · cited 1×
“In addition, the roles of both glucocorticoids and noradrenalinewere recently reported in habit memory [136].”
BackgroundPost, A., Ackl, N., Rücker, M., Schreiber, Y. A., Binder, E. B., Ising, M., Sonntag, A., Holsboer, F., & Almeida, O. F. X. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.007 · Cited by 35 · cited 1×
“Different studies have in fact sought to discriminate between subjects undergoing normal aging from those suffering from depression or AD through the measurement of the various APP cleavage products [101–104].”
BackgroundSelf-citationMicroglial activation is inhibited by corticosterone in dopaminergic neurodegeneration
Sugama, S., Takenouchi, T., Kitani, H., Fujita, M., & Hashimoto, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.016 · Cited by 30 · cited 1×
“In adrenalectomized mice (lacking endogenous production of GCs), dopamine neuronal loss was augmented following MPTP intoxication indicating that endogenous GCs do play a role in protecting dopamine neurons [159].”
BackgroundKapoor, R. C., Pathak, A., Kapoor, P., & Venugopalan, P. (2005) · Polyhedron · doi:10.1016/j.poly.2005.06.060 · Cited by 21
A case of early onset Parkinson's disease after major stress
Zheng, Z. S., Zou, K., Guo, W., Tang, G., & Zheng, B. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s48455 · Cited by 21 · cited 1×
“Indeed, the role of stress was proposed as one of the underlying causes of PD as clinical reports show that stress triggers the appearance of PD symptoms or exacerbates the motor symptoms [130–132].”
BackgroundDopamine Neurotransmission and Treatments for Parkinson's Disease in the Molecular Biology Era
Ogawa, N. (2008) · European Neurology · doi:10.1159/000113435 · Cited by 20
Research works printed but not linked: 4
- 1998, Endocrine Reviews, 19, 269
- 1998, Acta Neurologica Scandinavica, 97, 77
- 2007, Reviews in the Neurosciences, 18, 209
- 2012, Parkinsonism and Related Disorders, 18, S207
Cited by
Delirium pathophysiology: An updated hypothesis of the etiology of acute brain failure
Maldonado, J. R. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4823 · Cited by 617
“Glucocorticoids exert widespread actions in the CNS, ranging from the regulation of gene transcription, cellular signaling, modulation of synaptic structure, and transmission and glial function to behavior.(9) The neuroendocrine hypothesis proposes that, over time, repeated or prolonged high GC levels impair the abili…”
BackgroundNeuroinflammation pathways: a general review
Shabab, T., Khanabdali, R., Moghadamtousi, S. Z., Kadir, H. A., & Mohan, G. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1212854 · Cited by 632
“Moreover, anti-inflammatory agents improve the cognitive functions of AD patients [30,50].”
BackgroundThe Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders
Knezevic, E., Nenic, K., Milanovic, V., & Knezevic, N. N. (2023) · Cells · doi:10.3390/cells12232726 · Cited by 564
“Through an interplay of inflammation due to immune response and subsequent cytokine release and a lack of downregulation normally executed by GCs, neuroinflammation persists, leading to the atrophy of neurons in critical brain areas, such as the hippocampus [79,98].”
BackgroundInfluentialBisht, K., Sharma, K., & Tremblay, M.-È. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.003 · Cited by 360
Microglia, Lifestyle Stress, and Neurodegeneration
Madore, C., Yin, Z., Leibowitz, J., & Butovsky, O. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.003 · Cited by 311
“The dysregulated glucocorticoid rhythm in aging subjects is associated with chronic stress, which contributes to neurodegeneration (Vyas et al., 2016).”
Background
Metadata
- Authors
- Vyas, S., Rodrigues, A. J., Silva, J. M., Tronche, F., Almeida, O. F. X., Sousa, N., & Sotiropoulos, I.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Minho (PT)
- Laboratory of Gene Regulation and Adaptive Behaviors, Department of Neuroscience Paris Seine, INSERM U1130, CNRS UMR 8246, Université Pierre et Marie Curie, Paris Cedex 05, France
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Vyas, Sheela
- Sotiropoulos, Ioannis
- ORCID
- Venue
- Neural Plasticity
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-15
- ISSN
- 1687-5443 (ISSN-L)
- 2090-5904
- PMC
- PMC4806285
- OpenAlex
- W2300528976
- Semantic Scholar
- 99b9bd510118f9046bb460b580c03984bde62dcd
- Cited by
- 297
- References
- 176
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 37 · 2023: 27 · 2022: 31 · 2021: 36 · 2020: 38 · 2019: 26 · 2018: 29 · 2017: 13 · 2016: 8
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Neural Plasticity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Digital Library (submittedVersion, other-oa)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Fundação para a Ciência e a Tecnologia (PTDC/SAU-NMC/113934/2009, 13853, 13-BSV1-0013-02, DEQ20140329552)
- European Regional Development Fund (PTDC/SAU-NMC/113934/2009, 13853, 13-BSV1-0013-02, DEQ20140329552)
- Agence Nationale de la Recherche (PTDC/SAU-NMC/113934/2009, 13853, 13-BSV1-0013-02, DEQ20140329552)
- Fondation pour la Recherche Médicale (PTDC/SAU-NMC/113934/2009, 13853, 13-BSV1-0013-02, DEQ20140329552)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- chronic stress, glucocorticoids, glucocorticoid receptor, mineralocorticoid receptor, neuroplasticity, neurodegeneration, Alzheimer's disease, Parkinson's disease, stress hormones, cognitive disorders, mood disorders, gene transcription, synaptic transmission, glial function
- MeSH terms
- Alzheimer Disease, Animals, Brain, Glucocorticoids, Humans, Inflammation, Neuronal Plasticity, Parkinson Disease, Risk Factors, Stress, Psychological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.